Is ALVR or O a better dividend investment in 2026?

ALVR currently yields 20.39% with a 5% 5-year dividend growth rate. O yields 5.28% with 3.2% growth. The better choice depends on your goal: ALVR offers higher current income.

What is the dividend yield difference between ALVR and O?

ALVR has a forward dividend yield of 20.39% ($2.00/share annually). O yields 5.28% ($3.23/share annually). The yield gap is 15.11 percentage points.

Home › Compare › ALVR vs O

ALVR vs O: Dividend Comparison 2026

ALVR yields 20.39% · O yields 5.28%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 ALVR wins by $40.5K in total portfolio value

INVESTMENT

TIME HORIZON10 years

ALVR

● Live price

20.39%

Share price

$9.81

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$74.8K

Annual income

$7,021.90

Full ALVR calculator →

Realty Income Corporation

● Live price

5.28%

Share price

$61.15

Annual div

$3.23

5Y div CAGR

15.1%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$34.2K

Annual income

$5,102.74

Full O calculator →

Portfolio growth — ALVR vs O

📍 ALVR pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	ALVR	O
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, ALVR + O cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

ALVR pays

O pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ALVR

Annual income on $10K today (after 15% tax)

$1,732.93/yr

After 10yr DRIP, annual income (after tax)

$5,968.62/yr

Annual income on $10K today (after 15% tax)

$449.12/yr

After 10yr DRIP, annual income (after tax)

$4,337.33/yr

At 15% tax rate, ALVR beats the other by $1,631.29/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ALVR + O for your $10,000?

ALVR: 50%O: 50%

100% O50/50100% ALVR

Portfolio after 10yr

$54.5K

Annual income

$6,062.32/yr

Blended yield

11.12%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on O right now

ALVR

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Altman Z

-1.3

Piotroski

1/9

Analyst Ratings

Buy

Hold

Sell

Consensus: Hold

Price Target

$64.00

+4.7% upside vs current

Range: $60.00 — $69.00

Altman Z

1.0

Piotroski

5/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ALVR buys

O buys

No recent congressional trades found for ALVR or O in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricALVRO

Forward yield	20.39% ✓	5.28%
Annual dividend / share	$2.00	$3.23 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	15.1% ✓
Portfolio after 10y	$74.8K ✓	$34.2K
Annual income after 10y	$7,021.90 ✓	$5,102.74
Total dividends collected	$42.9K ✓	$20.7K
Payment frequency	quarterly	monthly
Sector	Stock	REIT
Analyst consensus	Buy	Hold

Year-by-year: ALVR vs O ($10,000, DRIP)

Year	ALVR Portfolio	ALVR Income/yr	O Portfolio	O Income/yr	Gap
1← crossover	$12,739	$2,038.74	$10,818	$608.16	+$1.9K → ALVR
2	$16,058	$2,427.19	$11,787	$741.68	+$4.3K → ALVR
3	$20,041	$2,859.40	$12,946	$911.00	+$7.1K → ALVR
4	$24,779	$3,335.27	$14,345	$1,127.94	+$10.4K → ALVR
5	$30,368	$3,854.01	$16,056	$1,409.05	+$14.3K → ALVR
6	$36,908	$4,414.23	$18,171	$1,777.83	+$18.7K → ALVR
7	$44,505	$5,013.90	$20,820	$2,268.21	+$23.7K → ALVR
8	$53,271	$5,650.48	$24,188	$2,929.90	+$29.1K → ALVR
9	$63,321	$6,320.94	$28,533	$3,837.11	+$34.8K → ALVR
10	$74,775	$7,021.90	$34,235	$5,102.74	+$40.5K → ALVR

ALVR vs O: Complete Analysis 2026

ALVR — Stock

Allovir, Inc., a clinical-stage cell therapy company, engages in the research and development of allogeneic, off-the-shelf multi-virus specific T cell (VST) therapies to prevent and treat devastating viral-associated diseases. The company's lead product is posoleucel, an allogeneic, off-the-shelf VST therapy, to treat BK virus, cytomegalovirus, adenovirus, Epstein-Barr virus, human herpesvirus 6, and JC virus. Its preclinical and clinical development product candidates include ALVR106 for the respiratory syncytial virus, influenza, parainfluenza virus, and human metapneumovirus; ALVR109 to treat SARS-CoV-2 and COVID-19; ALVR107 for treating hepatitis B; and ALVR108. The company was formerly known as ViraCyte, Inc. and changed its name to Allovir, Inc. in May 2019. Allovir, Inc. was founded in 2013 and is based in Waltham, Massachusetts.

Full ALVR Calculator →

O — REIT

Realty Income, The Monthly Dividend Company, is an S&P 500 company dedicated to providing stockholders with dependable monthly income. The company is structured as a REIT, and its monthly dividends are supported by the cash flow from over 6,500 real estate properties owned under long-term lease agreements with our commercial clients. To date, the company has declared 608 consecutive common stock monthly dividends throughout its 52-year operating history and increased the dividend 109 times since Realty Income's public listing in 1994 (NYSE: O). The company is a member of the S&P 500 Dividend Aristocrats index. Additional information about the company can be obtained from the corporate website at www.realtyincome.com.

Full O Calculator →

📬

Get this ALVR vs O comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ALVR vs SCHD ALVR vs JEPI ALVR vs KO ALVR vs MAIN ALVR vs STAG ALVR vs ADC ALVR vs NNN ALVR vs VICI

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.